Distrust of healthcare providers and may contribute to the low levels of compliance for breast cancer screening among minorities.
Distrust of healthcare providers and may contribute to the low levels of compliance for breast cancer screening among minorities.
A study by Michigan State University of 341 women, including African American, Arab American, and Hispanic women, found that more than two-thirds of those subjects believe that healthcare organizations sometimes mislead or even purposely deceive patients. The study was presented at the 2009 American Association for Cancer Research Conference on the Science of Cancer Health Disparities in Carefree, AZ.
Another study, in the Journal of Women’s Health, assessed the attitudes toward screening of 150 lesbian/bisexual and 400 heterosexual women. It revealed negative beliefs about mammography, lower levels of provider trust, and less perceived risk of breast cancer among lesbian/bisexual women (2009;18[2]:177-185).
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.